Atopic Dermatitis Control Falls Short of Patient Needs
Dermatology Times reports atopic dermatitis patients still need better disease control. The claim names a gap but gives no cohort, drug class, or effect size — here is what to verify.
Topic
Topic
Dermatology Times reports atopic dermatitis patients still need better disease control. The claim names a gap but gives no cohort, drug class, or effect size — here is what to verify.
Medscape's new feature asks why itch persists in atopic dermatitis as skin clears. The piece treats itch as its own clinical endp…
Everyday Health frames atopic dermatitis as an 'invisible' mental-health burden. The piece argues clinician-rated scores miss anx…
Cureus publishes a patient-reported outcomes study of Aptos thread-centered treatment in real-world aesthetic practice, expanding…
Patient stories collected by Dermatology Times reveal the hidden quality-of-life burden of chronic inducible urticaria, where eve…
An HCPLive feature reframes a central question in plaque psoriasis: what counts as treatment success, and how should durable remi…
A quality-of-life instrument built for pediatric dermatology patients has passed validation, per the European Medical Journal, of…
A new Cureus paper puts patient-reported outcomes at the center of Aptos thread-lift evaluation, reporting results from routine a…
A new review in Expert Opinion on Biological Therapy argues psoriasis success now spans symptoms, quality of life, preferences, a…
A Cureus study reports patient-reported outcomes after Aptos thread-centered facial treatment in real-world aesthetic practice, a…